PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31596974-1	2019	Innovative monocyclic beta-lactam entities create opportunities in the battle against resistant bacteria because of their PBP acylation potential, intrinsically high beta-lactamase stability and compact scaffold.	Monobactams	11-33	dedicator of cytokinesis 3	Homo sapiens	122-125	
31596974-7	2019	Furthermore, ring cleavage by representative beta-lactamases was ruled out, providing new insights in the SAR landscape of monocyclic beta-lactams as eligible PBP or beta-lactamase inhibitors.	Monobactams	123-146	dedicator of cytokinesis 3	Homo sapiens	159-162